Global caseload at 357.9 million amid ongoing Covid resurgence

The US continues to be the worst-hit country

A health worker sorts vials at a COVID-19 testing site amid concern over a third wave of the coronavirus pandemic in India, in New Delhi (Photo: PTI)
A health worker sorts vials at a COVID-19 testing site amid concern over a third wave of the coronavirus pandemic in India, in New Delhi (Photo: PTI)
IANS Washington
2 min read Last Updated : Jan 26 2022 | 10:14 AM IST

Amid an ongoing resurgence across the world, the global coronavirus caseload has topped 357.9 million, while the deaths have surged to more than 5.61 million and vaccinations to over 9.85 billion, according to Johns Hopkins University.

In its latest update on Wednesday morning, the University's Center for Systems Science and Engineering (CSSE) revealed that the current global caseload and the death toll stood at 357,963,895 and 5,614,043, respectively, while the total number of vaccine doses administered has increased to 9,850,294,423.

The US continues to be the worst-hit country with the world's highest number of cases and deaths at 72,171,208 and 871,937, according to the CSSE.

The second worst hit country in terms of cases is India (39,799,202 infections and 490,462 deaths), followed by Brazil (24,342,322 infections and 624,129 deaths).

The other countries with over 5 million cases are France (17,420,531), the UK (16,158,212), Turkey (11,090,493), Russia (11,055,246), Italy (10,212,621), Spain (9,395,767), Germany (8,956,528), Argentina (8,041,520), Iran (6,267,559) and Colombia (5,780,910), the CSSE figures showed.

The nations with a death toll of over 100,000 are Russia (320,844), Mexico (303,301), Peru (204,404), the UK (154,873), Indonesia (144,247), Italy (144,343), Colombia (132,737), Iran (132,274), France (130,483), Argentina (119,703), Germany (117,006), Ukraine (106,047) and Poland (104,097).

--IANS

int/sks/dpb

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

First Published: Jan 26 2022 | 10:14 AM IST

Next Story